Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.47 |
| ▸ | PLIN1 | O60240 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | RECQL | P46063 | 2/20 | 0.47 |
| ▸ | PLIN5 | Q00G26 | 2/20 | 0.47 |
| ▸ | ABHD5 | Q8WTS1 | 2/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.47 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1236317 | 0.83 | CYP2C19 (0.46) | CYP2C19HDAC1ALDH1A1LMNAHDAC3 | |
| SCHEMBL1618355 | 0.75 | CYP2C19 (0.58) | CYP2C19HDAC1ALDH1A1LMNAHDAC3 | |
| SCHEMBL28748361 | 0.73 | CYP2C19 (0.67) | CYP2C19HDAC1ALDH1A1LMNAHDAC3 | |
| SCHEMBL6067666 | 0.73 | CYP2C19 (0.67) | CYP2C19HDAC1ALDH1A1LMNAHDAC3 | |
| SCHEMBL30583099 | 0.73 | CYP2C19 (0.56) | CYP2C19HDAC1ALDH1A1LMNAHDAC3 | |
| SCHEMBL28655879 | 0.73 | CYP2C19 (0.56) | CYP2C19HDAC1ALDH1A1LMNAHDAC3 | |
| SCHEMBL1579975 | 0.71 | ALDH1A1 (0.46) | CYP2C19HDAC1ALDH1A1LMNAHDAC3 | |
| SCHEMBL3906269 | 0.71 | CYP2C19 (0.53) | CYP2C19HDAC1ALDH1A1LMNAHDAC3 | |
| (Z)-1,2-Diphenylethene SCHEMBL4532649 | 0.70 | HDAC1 (0.67) | HDAC1ALDH1A1LMNAHDAC3HDAC4 | |
| (Z)-1,2-Diphenylethene SCHEMBL980839 | 0.70 | HDAC1 (0.67) | HDAC1ALDH1A1LMNAHDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2028240-B1 | Phase change ink compositions | XEROX CORP (US) | 2016-02-10 | — | — | EP | disclosed |
| US-20150145920-A1 | METHOD OF JETTING INK | XEROX CORPORATION (US) | 2015-05-28 | — | — | US | disclosed |
| US-9022546-B1 | Method of jetting ink | XEROX CORPORATION (US) | 2015-05-05 | — | — | US | disclosed |
| US-8142557-B2 | Radiation curable ink containing gellant and radiation curable wax | XEROX CORPORATION (US) | 2012-03-27 | — | — | US | disclosed |
| US-7887176-B2 | High image quality in inkjet printing onto flexible packaging substrates of polyester, polypropylene, and aluminum foil, can be significantly improved by the use of radiation curable gel based phase change inks; not requiring pinning of the ink during color printing or nitrogen inerting during curing | XEROX CORPORATION (US) | 2011-02-15 | — | — | US | disclosed |
| EP-2223803-A1 | Preparation of flexographic printing masters using an additive process | Xerox Corporation (US) | 2010-09-01 | — | — | EP | disclosed |
| US-20100215865-A1 | PREPARATION OF FLEXOGRAPHIC PRINTING MASTERS USING AN ADDITIVE PROCESS | XEROX CORPORATION (US) | 2010-08-26 | — | — | US | disclosed |
| US-7504531-B2 | Processes for preparing difunctional compounds | XEROX CORPORATION (US) | 2009-03-17 | — | — | US | disclosed |
| EP-2028240-A1 | Phase Change Ink Compositions | Xerox Corporation (US) | 2009-02-25 | — | — | EP | disclosed |
| US-20080218570-A1 | IMAGING ON FLEXIBLE PACKAGING SUBSTRATES | XEROX CORPORATION (US) | 2008-09-11 | — | — | US | disclosed |
| US-20080204538-A1 | PRINTING ON CORRUGATED SUBSTRATES | XEROX CORPORATION (US) | 2008-08-28 | — | — | US | disclosed |
| US-20080000384-A1 | RADIATION CURABLE INK CONTAINING GELLANT AND RADIATION CURABLE WAX | XEROX CORPORATION (US) | 2008-01-03 | — | — | US | disclosed |
| US-20070255071-A1 | PROCESSES FOR PREPARING DIFUNCTIONAL COMPOUNDS | XEROX CORPORATION (US) | 2007-11-01 | — | — | US | disclosed |
| US-20070255038-A1 | Processes for preparing difunctional compounds | XEROX CORPORATION (US) | 2007-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070255071-A1 | PROCESSES FOR PREPARING DIFUNCTIONAL COMPOUNDS | ABL2, ABL1, PAICS | CYP2C19 902/4885HDAC1 3094/4885ALDH1A1 556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.